![](https://pharma.industry-report.net/wp-content/uploads/2019/07/USFDA-1.jpg)
Glenmark Pharma receives USFDA approval for Ranolazine tablets
Glenmark Pharma has received final USFDA approval for its Ranolazine extended-release tablets used for treatment of chronic angina. The drug Ranolazine extended-release tablets will be […]